Denali Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:DNLI Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
21 Aug 24	SellUS$200,401	Alexander Schuth	Individual	8,353	US$24.78
20 Aug 24	SellUS$41,085	Steve Krognes	Individual	1,727	US$23.79
20 Aug 24	SellUS$53,765	Ryan Watts	Individual	2,260	US$23.79
20 Aug 24	SellUS$58,357	Carole Ho	Individual	2,453	US$23.79
13 Aug 24	SellUS$53,494	Carole Ho	Individual	2,337	US$22.89
13 Aug 24	SellUS$52,006	Alexander Schuth	Individual	2,272	US$22.89
13 Jun 24	SellUS$14,992	Steve Krognes	Individual	688	US$21.79
13 Feb 24	SellUS$46,960	Alexander Schuth	Individual	2,716	US$17.29
13 Feb 24	SellUS$48,135	Carole Ho	Individual	2,784	US$17.29
13 Feb 24	SellUS$165,794	Ryan Watts	Individual	9,589	US$17.29
13 Feb 24	SellUS$47,548	Steve Krognes	Individual	2,750	US$17.29
10 Jan 24	SellUS$88,785	Carole Ho	Individual	4,668	US$19.02
09 Jan 24	SellUS$154,640	Ryan Watts	Individual	7,818	US$19.78
05 Jan 24	SellUS$339,695	Ryan Watts	Individual	17,483	US$19.43
05 Jan 24	SellUS$193,756	Alexander Schuth	Individual	9,972	US$19.43
05 Jan 24	SellUS$62,331	Steve Krognes	Individual	3,208	US$19.43
05 Jan 24	SellUS$193,756	Carole Ho	Individual	9,972	US$19.43

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DNLI?
Owner Type	Number of Shares	Ownership Percentage
General Public	429,429	0.298%
Individual Insiders	6,639,470	4.61%
Public Companies	7,155,243	4.97%
Institutions	129,697,482	90.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.1%.

Top Shareholders

Top 25 shareholders own 82.73% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.58%	BlackRock, Inc.	13,788,517	US$337.8m	4.66%	0.01%
9.27%	Baillie Gifford & Co.	13,345,887	US$327.0m	-3.03%	0.14%
7.77%	The Vanguard Group, Inc.	11,177,234	US$273.8m	-1.2%	no data
7.45%	Wellington Management Group LLP	10,727,450	US$262.8m	9.2%	0.04%
5.5%	Capital Research and Management Company	7,909,114	US$193.8m	11%	0.01%
5.44%	FMR LLC	7,828,372	US$191.8m	3,260%	0.01%
4.97%	Biogen Inc.	7,155,243	US$175.3m	-43.9%	no data
3.72%	Temasek Holdings (Private) Limited	5,355,832	US$131.2m	-6.14%	0.12%
3.1%	Crestline Investors Inc.	4,460,732	US$109.3m	-6.3%	6.01%
2.95%	State Street Global Advisors, Inc.	4,252,011	US$104.2m	-4.12%	no data
2.7%	UBS Asset Management AG	3,890,889	US$95.3m	59.9%	0.01%
2.59%	Baker Bros. Advisors LP	3,731,695	US$91.4m	0%	0.84%
2.12%	AllianceBernstein L.P.	3,047,264	US$74.7m	51%	0.02%
2.05%	Geode Capital Management, LLC	2,955,477	US$72.4m	-0.91%	no data
1.99%	T. Rowe Price Group, Inc.	2,869,795	US$70.3m	27.2%	0.01%
1.56%	Ryan Watts	2,241,211	US$54.9m	0%	no data
1.47%	Marc Tessier-Lavigne	2,111,441	US$51.7m	0%	no data
1.39%	Camber Capital Management LP	2,000,000	US$49.0m	0%	2.01%
1.37%	Marshall Wace LLP	1,967,141	US$48.2m	-18.7%	0.07%
1.08%	Dimensional Fund Advisors LP	1,559,442	US$38.2m	10%	0.01%
1.06%	Morgan Stanley, Investment Banking and Brokerage Investments	1,531,032	US$37.5m	48.5%	no data
1.06%	Credit Suisse Asset Management (Switzerland) Ltd.	1,519,295	US$37.2m	0%	0.04%
0.91%	BNY Asset Management	1,315,502	US$32.2m	-13.8%	0.01%
0.86%	Principal Global Investors, LLC	1,238,499	US$30.3m	13.8%	0.01%
0.76%	Artisan Partners Limited Partnership	1,091,018	US$26.7m	-4.42%	0.02%